Thomas Hallam
Director of Finance/CFO bij GIVAUDAN SA
Vermogen: 1 M $ op 29-02-2024
Profiel
Momenteel is Tom Hallam Chief Financial Officer bij Givaudan SA. De heer Hallam is ook lid van The Chartered Institute of Management Accountants. In zijn vorige carrière was de heer Hallam Vice President-Corporate Finance bij Serono SA. De heer Hallam behaalde een bachelordiploma aan de Universiteit van Manchester.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GIVAUDAN SA
0.00% | 31-12-2022 | 335 ( 0.00% ) | 1 M $ | 29-02-2024 |
Actieve functies van Thomas Hallam
Bedrijven | Functie | Begin |
---|---|---|
GIVAUDAN SA | Director of Finance/CFO | 01-01-2017 |
AZELIS GROUP NV | Director/Board Member | 02-08-2022 |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Director/Board Member | - |
Eerdere bekende functies van Thomas Hallam
Bedrijven | Functie | Einde |
---|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - |
Opleiding van Thomas Hallam
The University of Manchester | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GIVAUDAN SA | Consumer Non-Durables |
AZELIS GROUP NV | Distribution Services |
Bedrijven in privébezit | 3 |
---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Distribution Services |